HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 875171Generated: October 29, 2026
Diisopropylethylamine → N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester
https://huagongshe.com/reaction/875171
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Methyl valinate hydrochloride | HCID 111190 | — |
| Reactant | 4'-(Bromomethyl)-2-cyanobiphenyl | HCID 1501912 | — |
| Reactant | HCID 178447302 | HCID 178447302 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester | HCID 16744794 | — |
Reaction Steps
Bioorganic & Medicinal Chemistry Letters (1994), 4(1), 29-34, reported a process for the preparation of Valsartan by reacting 4′-bromomethyl-2-cyanobiphenyl (II) with (L)-valine methyl ester hydrochloride (V) in the presence of diisopropylethylamine in methylenechloride to produce N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine methyl ester (VI), followed by reacting with valeryl chloride in the presence of diisopropylethylamine in methylenechloride to produce N-valeryl-N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine methyl ester (VII), which is further reacted with tributyltin azide in xylene to produce N-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-N-valeryl-(L)-valine methyl ester (VIII), followed by hydrolysis with aqueous base to produce Valsartan of formula (I).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08981109B2 |
|---|
| Source dataset | uspto-grants-2015_03 |
|---|
| ORD ID | ord-5634e96350e143768c8515802b7759c6 |
|---|
| Source note | uspto-grants-2015_03 |
|---|